Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

Tracking RSV in low- and middle-income countries

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 621, S62-S63 (2023)

doi: https://doi.org/10.1038/d41586-023-02960-4

This article is part of Nature Outlook: Respiratory syncytial virus, a supplement produced with financial support from Moderna. Nature maintains full independence in all editorial decisions related to the content. About this content.

References

  1. Bardsley, M. et al. Lancet Infect. Dis. 23, 56–66 (2023).

    Article  PubMed  Google Scholar 

  2. Staadegaard, L. et al. Open Forum Infect. Dis. 8, ofab159 (2021).

    Article  PubMed  Google Scholar 

  3. World Health Organization. WHO Technical Meeting on Piloting RSV Surveillance based on the Global Influenza Surveillance and Response System (WHO, 2016).

    Google Scholar 

  4. World Health Organization. WHO Strategy for Global Respiratory Syncytial Virus Surveillance Project based on the Influenza Platform (WHO, 2019).

    Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links